It isnt listed as one of the common side effects of Ozempic , and it hasnt been reported in clinical trials
Presently, people with other qualifying conditions like obstructive sleep apnea and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) are eligible for Part D coverage of GLP-1 medications
Your provider will provide tips to manage side effects and ensure your comfort
Unveiling the Best Choice: A Recap and Look to the Future Now that weve delved into the details of semaglutide, Ozempic, Wegovy, and Mounjaro, lets revisit the key differences: Mechanism of Action: All four medications are GLP-1 receptor agonists, but Mounjaro has an additional mechanism targeting another gut hormone, potentially leading to increased weight loss effects
Cecilia Scott takes a client-centered approach, offering ongoing support and monitoring as your body adjusts to semaglutide GLP-1